Work

Photodynamic Therapy for Thyroid Cancer

Year: 2025

Type: article

Abstract: Background/Objectives: Thyroid cancer is the most common cancer of the en-docrine system worldwide. Despite many available therapeutic options, the mortality rate of some subtypes, including anaplastic thyroid cancer, is still sig-nificant. Photodynamic therapy brings hope, which, through local activation of cell death pathways, as well as its effect on the immune system and vessels feeding the tumor, brings effects incomparable to classical methods. Photosensi-tizers particularly used in the case of thyroid cancer are hypericin, porphyrin, photophrin, radachlorin or 5-aminolevulinic acid. Even better effects are achieved by administering sulforaphane, carboplatin or genistein before therapy Methods: For this research we review articles in regards to provide a critical summary of the existing literature on thyroid cancer to explain the current state of scientific evidence on this topic. Conclusions: Photodynamic therapy is undoubtedly a technique of the future, the main advantages of which are low invasiveness, the possibility of combining with other treatment methods, or the possibility of outpatient use.

Source: BioMed

DOI: 10.3390/biomed5010008

Authors: Julia Inglot, Joanna Katarzyna Strzelczyk, Dorota Bartusik-Aebisher, David Aebisher

Institutions: University of Rzeszów, Medical University of Silesia

Language: English

Topic: Photodynamic Therapy Research Studies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,207